Physicians at HonorHealth are excited to lead the fight against aggressive brain tumors with two new innovative clinical trials. The GESTALT trial is assessing the role of radioactive brachytherapy implantsLEARN MORE
HonorHealth is the first and only healthcare provider in Arizona approved to perform a new percutaneous transmural arterial bypass (PTAB) procedure. PTAB therapy provides a new treatment option for patientsLEARN MORE
Registration is now open for the 2023 Neuroscience Institute Symposium! All members of the HonorHealth Medical Staff are invited to attend this two-day event for free because of a generousLEARN MORE
When Lou Gehrig played first base for the New York Yankees 100 years ago, he was by any era’s standards a physical specimen, eventually playing in what then was aLEARN MORE
Erkut Borazanci, MD, explains discoveries surrounding the possibility of targeting the glucocorticoid receptor with experimental drug HonorHealth Research Institute oncologist Erkut Borazanci, MD, describes how a Phase 2 clinical trial forLEARN MORE
Novel therapy initiated in first patient with drug-resistant melanoma skin cancer For the first time, an HonorHealth patient has been treated with tumor infiltrating lymphocytes, or TILs, at HonorHealth ResearchLEARN MORE
Clinical trial at HonorHealth Research Institute shows substantial drop in laboratory radiation, with most cases producing undetectable radiation exposure to cardiology staff HonorHealth Research Institute announced today that it isLEARN MORE
HonorHealth’s first cardiovascular endovascular graft procedure was successfully completed by Venkatesh Ramaiah, MD, and his team at HonorHealth Scottsdale Osborn Medical Center. The procedure is used for treating patients withLEARN MORE
At the HonorHealth Research Institute, patients have access to tomorrow’s cure today. In existence since 2005, the institute focuses on creating innovative medical advances for today’s most pressing health concerns.LEARN MORE
Congratulations to Joseph Mikhael, MD, consultant hematologist and director of myeloma research at the HonorHealth Research Institute, for being selected as one of the newest members of the American Cancer SocietyLEARN MORE
